BIOMAT Database Logo BIOMAT Database Logo

Discovery of 5-substituted pyrrolo[2,3-d]pyrimidine antifolates as dual-acting inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis: implications of inhibiting 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase to ampk activation and antitumor activity. 2013

Shermaine Mitchell-Ryan, and Yiqiang Wang, and Sudhir Raghavan, and Manasa Punaha Ravindra, and Eric Hales, and Steven Orr, and Christina Cherian, and Zhanjun Hou, and Larry H Matherly, and Aleem Gangjee
Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201.

We synthesized 5-substituted pyrrolo[2,3-d]pyrimidine antifolates (compounds 5-10) with one-to-six bridge carbons and a benozyl ring in the side chain as antitumor agents. Compound 8 with a 4-carbon bridge was the most active analogue and potently inhibited proliferation of folate receptor (FR) α-expressing Chinese hamster ovary and KB human tumor cells. Growth inhibition was reversed completely or in part by excess folic acid, indicating that FRα is involved in cellular uptake, and resulted in S-phase accumulation and apoptosis. Antiproliferative effects of compound 8 toward KB cells were protected by excess adenosine but not thymidine, establishing de novo purine nucleotide biosynthesis as the targeted pathway. However, 5-aminoimidazole-4-carboxamide (AICA) protection was incomplete, suggesting inhibition of both AICA ribonucleotide formyltransferase (AICARFTase) and glycinamide ribonucleotide formyltransferase (GARFTase). Inhibition of GARFTase and AICARFTase by compound 8 was confirmed by cellular metabolic assays and resulted in ATP pool depletion. To our knowledge, this is the first example of an antifolate that acts as a dual inhibitor of GARFTase and AICARFTase as its principal mechanism of action.

UI MeSH Term Description Entries
D007624 KB Cells This line KB is now known to be a subline of the ubiquitous KERATIN-forming tumor cell line HeLa. It was originally thought to be derived from an epidermal carcinoma of the mouth, but was subsequently found, based on isoenzyme analysis, HeLa marker chromosomes, and DNA fingerprinting, to have been established via contamination by HELA CELLS. The cells are positive for keratin by immunoperoxidase staining. KB cells have been reported to contain human papillomavirus18 (HPV-18) sequences. HeLa-KB Cells,Cell, HeLa-KB,Cell, KB,Cells, HeLa-KB,Cells, KB,HeLa KB Cells,HeLa-KB Cell,KB Cell
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011685 Purine Nucleotides Purines attached to a RIBOSE and a phosphate that can polymerize to form DNA and RNA. Nucleotides, Purine
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D003412 Cricetulus A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research. Hamsters, Armenian,Hamsters, Chinese,Hamsters, Grey,Armenian Hamster,Armenian Hamsters,Chinese Hamster,Chinese Hamsters,Grey Hamster,Grey Hamsters,Hamster, Armenian,Hamster, Chinese,Hamster, Grey
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005493 Folic Acid Antagonists Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) Antifolate,Antifolates,Dihydrofolate Reductase Inhibitor,Folic Acid Antagonist,Dihydrofolate Reductase Inhibitors,Folic Acid Metabolism Inhibitors,Acid Antagonist, Folic,Acid Antagonists, Folic,Antagonist, Folic Acid,Antagonists, Folic Acid,Inhibitor, Dihydrofolate Reductase,Inhibitors, Dihydrofolate Reductase,Reductase Inhibitor, Dihydrofolate,Reductase Inhibitors, Dihydrofolate

Related Publications

Shermaine Mitchell-Ryan, and Yiqiang Wang, and Sudhir Raghavan, and Manasa Punaha Ravindra, and Eric Hales, and Steven Orr, and Christina Cherian, and Zhanjun Hou, and Larry H Matherly, and Aleem Gangjee
Discovery of 6-substituted thieno[2,3-d]pyrimidine analogs as dual inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis in folate receptor expressing human tumors.
May 2021, Bioorganic & medicinal chemistry,
Shermaine Mitchell-Ryan, and Yiqiang Wang, and Sudhir Raghavan, and Manasa Punaha Ravindra, and Eric Hales, and Steven Orr, and Christina Cherian, and Zhanjun Hou, and Larry H Matherly, and Aleem Gangjee
A multifunctional protein possessing glycinamide ribonucleotide synthetase, glycinamide ribonucleotide transformylase, and aminoimidazole ribonucleotide synthetase activities in de novo purine biosynthesis.
December 1985, Biochemistry,
Shermaine Mitchell-Ryan, and Yiqiang Wang, and Sudhir Raghavan, and Manasa Punaha Ravindra, and Eric Hales, and Steven Orr, and Christina Cherian, and Zhanjun Hou, and Larry H Matherly, and Aleem Gangjee
Pyrazofurin inhibition of purine biosynthesis via 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranosyl 5'-monophosphate formyltransferase.
May 1980, Cancer research,
Shermaine Mitchell-Ryan, and Yiqiang Wang, and Sudhir Raghavan, and Manasa Punaha Ravindra, and Eric Hales, and Steven Orr, and Christina Cherian, and Zhanjun Hou, and Larry H Matherly, and Aleem Gangjee
De novo purine nucleotide biosynthesis: cloning, sequencing and expression of a chicken PurH cDNA encoding 5-aminoimidazole-4-carboxamide-ribonucleotide transformylase-IMP cyclohydrolase.
October 1991, Gene,
Shermaine Mitchell-Ryan, and Yiqiang Wang, and Sudhir Raghavan, and Manasa Punaha Ravindra, and Eric Hales, and Steven Orr, and Christina Cherian, and Zhanjun Hou, and Larry H Matherly, and Aleem Gangjee
Synthesis of classical, three-carbon-bridged 5-substituted furo[2,3-d]pyrimidine and 6-substituted pyrrolo[2,3-d]pyrimidine analogues as antifolates.
December 2004, Journal of medicinal chemistry,
Shermaine Mitchell-Ryan, and Yiqiang Wang, and Sudhir Raghavan, and Manasa Punaha Ravindra, and Eric Hales, and Steven Orr, and Christina Cherian, and Zhanjun Hou, and Larry H Matherly, and Aleem Gangjee
Synthesis of classical, four-carbon bridged 5-substituted furo[2,3-d]pyrimidine and 6-substituted pyrrolo[2,3-d]pyrimidine analogues as antifolates.
August 2005, Journal of medicinal chemistry,
Shermaine Mitchell-Ryan, and Yiqiang Wang, and Sudhir Raghavan, and Manasa Punaha Ravindra, and Eric Hales, and Steven Orr, and Christina Cherian, and Zhanjun Hou, and Larry H Matherly, and Aleem Gangjee
Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidines as potential nonclassical antifolates targeting both thymidylate and purine nucleotide biosynthesis.
March 2015, European journal of medicinal chemistry,
Shermaine Mitchell-Ryan, and Yiqiang Wang, and Sudhir Raghavan, and Manasa Punaha Ravindra, and Eric Hales, and Steven Orr, and Christina Cherian, and Zhanjun Hou, and Larry H Matherly, and Aleem Gangjee
De novo purine nucleotide biosynthesis: cloning of human and avian cDNAs encoding the trifunctional glycinamide ribonucleotide synthetase-aminoimidazole ribonucleotide synthetase-glycinamide ribonucleotide transformylase by functional complementation in E. coli.
November 1990, Nucleic acids research,
Shermaine Mitchell-Ryan, and Yiqiang Wang, and Sudhir Raghavan, and Manasa Punaha Ravindra, and Eric Hales, and Steven Orr, and Christina Cherian, and Zhanjun Hou, and Larry H Matherly, and Aleem Gangjee
Case report of a rare purine synthesis disorder due to 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase (AICAR) deficiency.
October 2022, Brain & development,
Shermaine Mitchell-Ryan, and Yiqiang Wang, and Sudhir Raghavan, and Manasa Punaha Ravindra, and Eric Hales, and Steven Orr, and Christina Cherian, and Zhanjun Hou, and Larry H Matherly, and Aleem Gangjee
Discovery of amide-bridged pyrrolo[2,3-d]pyrimidines as tumor targeted classical antifolates with selective uptake by folate receptor α and inhibition of de novo purine nucleotide biosynthesis.
December 2019, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!